Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| NCI-2018-00390 | Registry Identifier | CTRP (Clinical Trial Reporting Program) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This phase I trial studies how well indocyanine green lymphangiography works in identifying thoracic duct during neck surgery. Diagnostic procedures, such as near infrared fluorescence imaging with indocyanine green may help recognize and prevent injury to thoracic duct during neck surgery.
PRIMARY OBJECTIVES:
I. Feasibility and optimization of thoracic duct identification using indocyanine green (ICG) lymphangiography.
II. To explore specifically how identifying the thoracic duct (TD) will prevent injury intra-operatively.
III. To understand if a TD injury can be recognized by leakage of fluorescent chyle into the operating field.
OUTLINE:
Participants receive indocyanine green solution subcutaneously (SC) and undergo near-infrared imaging over 1-2 minutes during their standard of care neck surgery.
After completion of study treatment, participants are followed up for up to 1 year.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Treatment (ICG lymphangiography) | Experimental | Participants receive indocyanine green solution SC and undergo near-infrared imaging over 1-2 minutes during their standard of care neck surgery. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Indocyanine Green Solution | Other | Given Subcutaneous injection |
|
| Measure | Description | Time Frame |
|---|---|---|
| Identify thoracic duct (TD) using indocyanine green (ICG) | We will determine in how many patients the thoracic duct is identified by white light visualization and by ICG fluorescence. The collected data will be primarily qualitative as determined by the surgeon. | Up to 1 year |
| Prevent injury to the TD | Percentage of patients with TD injury will be calculated and compared to contemporary rates of injury. | Up to 1 year |
| Recognize injury intra-operatively | Will be mostly qualitative data collection on how the injury was identified and in what percent. | Up to 1 year |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John Phay, MD | Ohio State University Comprehensive Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | United States |
Not provided
| Label | URL |
|---|---|
| The Jamesline | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007208 | Indocyanine Green |
| ID | Term |
|---|---|
| D007211 | Indoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Lymphangiography | Procedure | Undergo lymphangiography |
|
|